ABNORMAL-METABOLISM OF VALPROIC ACID IN FATAL HEPATIC-FAILURE
ABNORMAL-METABOLISM OF VALPROIC ACID IN FATAL HEPATIC-FAILURE
复制标题
DOI:
10.1007/bf00445664
复制
发表时间:
1983-01-01
影响因子:
3.6
通讯作者:
RITZ, A
中科院分区:
文献类型:
--
作者:
KOCHEN, W;SCHNEIDER, A;RITZ, A
A 7-yr-old boy developed a severe unilateral grand mal seizure at the age of 5 yr (phenobarbitone therapy); 1.5 yr later valproate (2-propylpentanoic acid, VPA) was added to the therapy. After a seizure-free period of 3 mo. the patient died from hepatic failure resmebling Reye syndrome. Several plasma and urine samples from the final stage before and during peritoneal dialysis were analyzed by GC/MS [gas chromatography/mass spectroscopy]. The predominant feature was the abnormally increased formation of both 3 mono- and 4 double unsaturated metabolites of VPA amounting in plasma to 58-71% of the sum of VPA plus all analyzed metabolites (controls maximal 15%) and in urine to 34-61% (controls maximal 10%). The beta-oxidation pathway of VPA was suppressed (lack of 3-keto-VPA), whereas metabolites from the omega-oxidation pathway could still be measured (urinary 5-OH-VPA plus 2-propylglutaric acid .apprx. 16%, controls more than 10%). 4-en-VPA (2-propyl-4-pentenoic acid) (5-21% in plasma) and 4,4''-dien-VPA (2(2-propenyl)-4-pentenoic acid) (4-7%) was found as abnormal unsaturated metabolites not detectable in controls. Additional typical findings were the high excretion of adipic acid, suberic acid and 4-octen-1,8-dicarboxylic acid demonstrating the enhanced capacity of omega-oxidation in fatty acid oxidation.